A forum member expressed strong skepticism regarding non-pharmaceutical IGF-1 LR3, labeling products from peptide companies as low quality. They suggested that only pharmaceutical versions like Increlex are worth the investment.
A forum member expressed strong skepticism regarding non-pharmaceutical IGF-1 LR3, labeling products from peptide companies as low quality. They suggested that only pharmaceutical versions like Increlex are worth the investment.